Find Academic Supervisors

Mary WyerView profile

Associate Professor

• High-consequence Infectious Diseases (HCIDs)
• Infection Prevention and Control
• Biocontainment Practices
• +4 more

Dr. Mary Wyer is an Associate Professor of Practice (Biocontainment) at the University of Sydney’s Susan Wakil School of Nursing and Midwifery, affiliated with the Sydney Infectious Diseases Institute and the NSW Biocontainment Centre. She holds a PhD in infection prevention and control (2017) and has extensive experience in biocontainment and qualitative research. Her roles are supported by the Western Sydney Local Health District. **Education**: PhD (2017), RN, MACN. Research interests include high-consequence infectious diseases (HCIDs), outbreak management, infection prevention, qualitative methods, and patient involvement in healthcare. She leads projects on biocontainment preparedness, using video-reflexive ethnography to improve clinical practices. **Current Projects**: Strengthening bio-preparedness via simulation and video-reflexive methods; 24-hour in situ simulations for biocontainment centre readiness; aged care infection control strategies; and establishing national infection control standards. She co-leads the Australian BioCOP network for HCID collaboration. **Key Contributions**: Authored/co-authored over 30 peer-reviewed publications, including a book on video-reflexive ethnography. Awards include the 2019 Best Poster Award (ACIPC) and recognition for innovation in infection control research. **Grants**: Secured $2.3M+ in funding for research projects, including NHMRC grants and partnerships with UTS and NSW Health.

• Infectious Diseases
• Antimicrobial Resistance
• Bacteriology
• +7 more

Clinical Associate Professor Matthew O'Sullivan is an academic at the University of Sydney's Westmead Clinical School, affiliated with the Department of Medicine. He holds memberships in the Sydney Infectious Diseases Institute (Sydney ID) and has expertise in infectious diseases and medical microbiology. His clinical work focuses on staphylococcal infections, tropical medicine, HIV, and high consequence infectious diseases (HCIDs) like Ebola and COVID-19. He also specializes in genotyping-based surveillance of hospital-acquired pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). Dr. O'Sullivan graduated with an MBBS from the University of Queensland (1996). He later obtained a Master of Medicine (Clinical Epidemiology) from the University of Sydney and a PhD (2013) for his thesis on MRSA typing systems. He also holds a Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine. His research interests span molecular epidemiology of bacterial pathogens, particularly MRSA, and translational applications of microbial genotyping in infection control. He actively explores HCID clinical biocontainment protocols, SARS-CoV-2 transmission dynamics, and diagnostic methodologies for emerging viral threats. His work emphasizes integrating genomic data with clinical practice to improve antimicrobial stewardship and outbreak management. Recent studies include the ASCOT ADAPT adaptive platform trial for MRSA therapeutics and the SABRes project analyzing SARS-CoV-2 drug resistance mutations. He has contributed to national pandemic response initiatives through genomic surveillance and seroprevalence studies. Dr. O'Sullivan has led multiple grants including NHMRC-funded projects on MRSA transmission and genomic analysis. His work involves collaboration with major institutions like the National Health and Medical Research Council (NHMRC) and the Sydney ID team. He has not listed any formal advisees in his profile. His contributions to infection control include developing the mPCR/RLB binary typing system and evaluating diagnostic assays like the BD Max StaphSR. He advocates for patient-centered approaches in preventing healthcare-associated infections through visual ethnography and clinician feedback mechanisms.

Hugh AdlerView profile

Research Fellow

• Infectious Diseases
• Tropical Medicine
• Pneumococcal Research
• +3 more

Hugh Adler is an Honorary Research Fellow at the Department of Clinical Sciences within the Liverpool School of Tropical Medicine and a Specialty Trainee in Infectious Diseases at Liverpool University Hospitals NHS Trust . His work bridges clinical research and tropical medicine, focusing on pneumococcal colonization, antimicrobial resistance, and emerging infections like monkeypox. Education : Medicine at University College Dublin , followed by a diploma in tropical medicine and hygiene at LSTM. Hugh's research centers on experimental human pneumococcal colonization (EHPC) , expanding its application to older populations and refining its safety and immunological implications. He has contributed to understanding post-vaccination pneumococcal epidemiology and led studies on influenza-pneumococcus interactions. His clinical experience includes managing monkeypox cases and collaborating with the UK's High Consequence Infectious Diseases (HCID) network. Hugh teaches on the DTM&H and MSc Tropical and Infectious Diseases programs. He has published extensively on pneumococcal dynamics, viral-bacterial co-infections, and monkeypox epidemiology, often working with interdisciplinary teams to address global health challenges. Research Affiliations : Member of the Experimental Human Pneumococcal Carriage (EHPC) collaboration . Collaborated with the National HCID Network for monkeypox studies.

• Pediatric Infectious Diseases
• Immunology
• Tuberculosis (TB) Research
• +5 more

Elizabeth Whittaker is a Professor of Practice in Paediatric Infectious Diseases and Immunology at Imperial College London's Faculty of Medicine, with clinical roles as a Consultant in Paediatric Infectious Diseases at St Mary's Hospital. She leads research and clinical initiatives in high-consequence infectious diseases (HCIDs), paediatric TB, and post-COVID-19 conditions. Key roles include National Clinical Lead for HCIDs in children (NHSE), Director of Research at West London Children's Healthcare (WLCH), and co-lead for HCID at Imperial College Healthcare NHS Trust. Affiliations: Centre for Paediatrics and Child Health (PaeCH), Vaccine Research Network, British Paediatric Allergy Infection and Immunity Group (BPAIIG), and PTBNET. Educations: MB BAO BCH (Trinity College Dublin, 2002), PhD in Immune responses to mycobacteria (Imperial College London, 2013), DTM&H (Gorgas Course, 2009). Her research focuses on infant immune development, TB susceptibility, and vaccine hesitancy, with emphasis on global collaboration. She leads projects like the Teen TB cohort study and contributes to WHO guidelines on paediatric TB. Her work addresses viral co-infections, genetic predisposition to severe infections, and long-term outcomes of emerging diseases like monkeypox and MIS-C. Publications highlight her expertise in post-COVID-19 syndrome, HCID management, and vaccination policy. Awards include the Bruno Orsi Medal for research excellence. She chairs national committees on TB, HCIDs, and vaccine hesitancy, advocating for integrated clinical-research pathways in child health. Grants & Funding: Wellcome Trust (PhD), multiple NHS research grants, and international collaborations through the IMPRINT and INVAR networks. Labs/Teams: Leads the Imperial College Paediatric Infectious Diseases Research Group and collaborates with SATVI (South Africa) on TB research.

• Infectious Diseases
• Virology
• Clinical Medicine
• +7 more

Dr. Matthias Schmid is a researcher affiliated with Newcastle University , focusing on infectious diseases, virology, and clinical medicine. His work spans epidemiology, public health, and immunology, with significant contributions to understanding HIV, malaria, Hepatitis C, and SARS-CoV-2 dynamics. Key Research Areas: Infectious disease management, antiretroviral therapy, viral mutation analysis, and mucosal immunity. Clinical Expertise: High-consequence infectious diseases (HCID), complication management in viral infections, and pandemic response protocols. Education & Policy: Involved in medical elective recommendations and global health education frameworks. Recent publications highlight his focus on SARS-CoV-2 immunity, monkeypox clinical features, and energy-efficient building technologies, demonstrating interdisciplinary engagement. Collaborations span NHS institutions, TropNet surveillance networks, and international research consortia.